Prospera Financial Services Inc Veracyte, Inc. Transaction History

Prospera Financial Services Inc

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Aug 08, 2022	SELL	$15.45 - $29.52 $67,423 - $128,825	-4,364 Reduced 94.66%	246 $5,000
Q1 2022 May 04, 2022	BUY	$21.94 - $42.51 $101,143 - $195,971	4,610 New	4,610 $127,000
Q4 2020 Feb 12, 2021	SELL	$32.49 - $61.88 $124,566 - $237,247	-3,834 Closed	0 $0
Q3 2020 Nov 04, 2020	BUY	$26.73 - $35.67 $102,482 - $136,758	3,834 New	3,834 $125,000

339

80.4M

212K

18.5K

Ticker VCYT
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 71,575,904
Market Cap $2.28B
Description
Veracyte, Inc. operates as a diagnostics company worldwide. The company offers Afirma Genomic Sequencing Classifier and Xpression Atlas, which are used to determine patients with indeterminate results are benign to avoid unnecessary surgery; Decipher Prostate Biopsy and Radical Prostatectomy for prostate cancer diagnosis; Prosigna Breast Cancer ...

Get notified when there are updates to the investment portfolio of Prospera Financial Services Inc, based on Form 13F filings with the SEC.

Stay updated on Prospera Financial Services Inc with notifications on news.